The boxplot demonstrated that SLPI is down-regulated in prostate cancer patients, while the CENPF, TOP2A and OR51E2 are up-regulated in prostate cancer patients compared with the normal cohort (Figures 7F–I). The gene discussed is TOP2A; the disease is prostate cancer.